Feifei Zhuang et al. [123] found that pyrroline-5-carboxylate reductase 3 (PYCR3) is significantly upregulated in TNBC tumor tissues, and it promotes drug resistance by increasing mtDNA copy number and mitochondrial respiration. Here, PYCR3 is linked to neoplasm.